Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Langlui, there are only a handfull of people on this board that I really pay attention to ( and I feel it's one of the best boards on IHUB ). Hammer is one of those people. I don't play everything he posts but when he does post something, I will look at it and then do my own DD. I always go thru the same DD,look at why someone is recomending it, market cap, # shares, recent chart to see if it's already had a move ( don't want to be too late to the party), average daily volume, current volume, etc.. I don't just take someones word for it and buy. Also everyone has their own style. I have made some nice money on some of Hammer's bio calls selling before the FDA news ( I usually don't like to hold into the news. ).
Overall I have made money with his calls. BUT I am still in IDLM, IWEB and GARB and are down ( haven't sold any yet - - still have faith).
Stocks/stories don't always play out the way we'd like, sometimes it takes longer, sometimes it turns bad, etc. I think he puts his money where is mouth is and has the right intentions.
He is an asset to this board.
IDLM filed it's 10Q today. Are we on our way?
I believe it is Chris Hempel
Octagramt,
I spoke to the company a few weeks ago and ask specifically when it was submitted and was told 3/10
Curber,
I was told that the application was sumitted on 3/10/10. So as I understand it an FDA reply is required within 60 days ( 5/10 ).
ghmm,
I have been in CTDH for over 4 years and spoken to the CEO, Rick Strattan many times ( his name and phone # are at the bottom of all their press releases) ( actually, I spoke to him today because I wanted to know when the 10k was coming out and had some other questions ). I would suggest talking to him about your questions ( I bet once you do, you will see that this company has a great future ).
10K will be today
Cyclone101,
I've been in this one for 4 years now and I'm waiting for the dollars. I think we are close, very close.
die BBBY
Buying BBBY Jan 42 PUTS
they post earnings Jan 6th
LVSG: .088 x .089 to end the day. I think we should see .10 soon.
PCES - Shac, need to add to your list. Got some action today.
Bill
MYRG - .3725 x .3950 :) eom.
MYRG - 30 x 35 looking good as it marches upward imho.
MYRG .23 x .27 now. eom
MYRG bought more here.
ADZR .023 x .025 eom.
ZKID - news out.
10:01 ET CHICAGO--(BUSINESS WIRE)--Feb. 25, 2003--Zkid Network Company,
Inc. (OTCBB: ZKID.U) and KidSational, Inc. (OTCBB: KDSC.u) sign
multi-product software distribution agreement that will combine the
ZKID Mcgruff(R) Kidskeep(R) state of the art proprietary software and
the Mcgruff(R) Safe Kids Identification Kit with all of Kidsational's
cutting edge educational teaching products which include The Guardian
Safety Game already utilized in over 400 schools and institutions.
The Zkid Mcgruff(R) Kidskeep(R) distribution agreement will occur
concurrently with KidSational's flagship project, "Guardian-Masters of
Electro-World" a major motion picture, currently in production, "
Think Safe" a revolutionary new game show based on the Guardian's
Safety Game is projected to be carried in 75% of the nations schools
by cable in the classroom, "The Guardians Performance Group" a band of
teenage role models that will tour nationally to America's elementary
youth, the "Safety Shoe" an internationally patented children's shoe
and several other productions are slated for this year.
Zkid Network Company CEO Jon Darmstadter, states that "we are very
excited about this agreement that creates multiple marketing
opportunities which allows Zkid to distribute the greatest number of
Zkid Mcgruff(R) Kidskeep(R) software, meeting its mandate to build a
subscriber based network while also adding several additional sources
of revenue."
KidSational COO Lee Vanatta states "our project has inspired the
dedication of award winning music and production management as well as
celebrities and sponsors from stage, film, radio, sports, politicians
and educators from around the world."
ZKID Network Company is a proprietary software company dedicated
to providing a totally safe Internet environment for children. ZKid's
product provides safe Internet, e-mail and chat room capabilities as
well as fully animated original educational/entertainment content to
children ages 4-10. Subscribers can participate in a virtual private
network (VPN) specifically designed to provide a totally safe Internet
environment for children. The company's proprietary software is now
available in CD for distribution on a subscriber basis to a target
market of more than 60 million net users and 30 million children who
use the Internet in the U.S., and millions more overseas. Zkid Network
Company, Inc. is an official licensee of the National Crime Prevention
Council / Milstein Center For Online Protection and has the right to
distribute McGruff (R), Scruff (R), and "Take A Bite Out Of Crime"
licensed products. For additional information visit our Website:
www.zkidnetwork.com or Contact: James Hunter Zkid Network Company,
Inc. 1-800-787-5439.
KidSational: Founded in 1999 to become a leading distributor of
cutting edge thematic educational programming and teaching aids that
focus on children's safety and well-being. Product lines include:
books, CD's Board Games, Virtual Games, Television Shows, Toys,
Clothing and is now expediting the most comprehensive, and
entertaining children's education system in the world.
Safe Harbor Provisions
Some of the statements contained in this press release discuss
future expectations, projections of sales, results of operations,
financial conditions or licensee production or state other
"forward-looking" information (as defined in Section 21E of the
Securities Exchange Act of 1934). Such information can be identified
by the use of "may," "will," "should," "expect," " anticipate,"
"estimate," "continue," or other similar words. These statements are
subject to known and unknown risks, uncertainties and other factors
that could cause actual results to differ materially from those
contemplated by the statements. When considering such forward-looking
statements, the reader should keep in mind these risk factors and
their possible implications. Because the Company's common stock is
considered a "penny stock," as defined by the regulations ofthe
Securities and Exchange Commission, the safe harbor for
forward-looking statements does not apply to statements made by the
Company.
The Company believes that the information contained in this press
release is accurate as of its date of publication. The Company
disclaims any obligation to update information it has released. This
release may appear on a website that contains links or frames to sites
operated by third parties. The Company assumes no responsibility for
the accuracy or completeness of information on such third-party sites.
--30--RC/ny*
CONTACT: Zkid Network Company, Chicago
James Hunter, 800/787-5439
integritas@visi.com
www.zkidnetwork.com
VNCO - news.
Vencor Wins International Distribution Contract
and Worldwide License for Efoora/Vencor HIV
Rapid Test
Tuesday February 18, 8:08 am ET
LOS ANGELES--(BUSINESS WIRE)--Feb. 18, 2003--Vencor International, Inc. (Pink
Sheets:VNCO - News) today announced that an agreement has been finalized with
Efoora, Inc. to distribute and license internationally (excluding all of North America) the
Efoora/Vencor HIV Rapid Test. Building on its international business relationships
around the world, management of Vencor will solidify distribution channels in Europe,
Africa, Asia, Central and South America.
With HIV reaching epidemic proportions, the need for a rapid diagnostic test is
imperative. In many underdeveloped countries surveillance and screening tests are
expensive, time consuming and difficult to administer. The difficulty in locating the
infected person after the test is taken and the possibility of an infected individual
continuing to spread the disease until notified makes it obvious that the need for an
accurate and rapid HIV test has become a critical solution to controlling HIV growth.
The Efoora/Vencor HIV Rapid Test has been evaluated and determined to be as valid
as traditional tests, at a fraction of the time and cost. This one-step rapid diagnostic
test is sensitive to HIV-1, HIV-2 and Group "O" infections, and gives laboratory-grade
test results, as verified in recent third-party clinical trials. The Efoora/Vencor Rapid HIV
Test works with plasma, serum or whole blood. A special procedural control zone
accompanies each test kit to confirm the test was run correctly. In only twenty minutes,
patients and doctors receive definitive answers. Several clinical trials of the
Efoora/Vencor HIV Rapid Test have shown sensitivity of greater than 98% and
specificity of greater than 98%.
The Food and Drug Administration (FDA) has approved the Efoora/Vencor HIV Rapid
Test for export around the world subject to Section 802 of the Federal Food, Drug and
Cosmetic Act. A Certificate of Exportability was issued by the FDA and the Department
of Health and Human Services.
In addition to President Bush's renewed commitment to fighting HIV, government
leaders all over the world are putting efforts and resources towards fighting this medical
calamity. International governments have mandated more frequent testing of at risk
citizens and are providing financial support to purchase new effective preventative tests
and services.
Vencor will provide a desperately needed service and Efoora's cutting edge technology
to the international medical establishment and government agencies around the world.
Management believes revenues will be very significant and will publish quarterly sales
estimates when they become available.
Management has retained special legal counsel to expedite the move of Vencor's listing
back to the Nasdaq Bulletin Board from the Pink Sheets. Additionally, an international
investment firm has extended the company a line of credit to ensure that Vencor's
management team has enough operating capital to fully market the Efoora/Vencor HIV
Rapid Test around the world.
Safe Harbor Statement
This announcement contains forward looking statements that involve risks and
uncertainties that include, among others, the Company's unpredictability of future
revenues, potential fluctuations in quarterly operating results, seasonality, competition,
risks associated with system development and operation risks, management of
potential growth and risks of new business areas and strategic alliances.
Contact:
Vencor International, Inc.
Ben Armijo, 213/748-1988
ben_utopia@sbcglobal.net
OPLO - from their website.
February 13, 2003
Letter to the shareholders:
We have received several questions regarding the timeline and execution of this offer. In order to eliminate some of the confusion, we would like to clarify
some details.
The company's SEC legal counsel is preparing a document that will clearly define the process of the actual execution and will be provided to all OrderPro Logistics' shareholders of
record as of close of business February 18, 2003. These documents will be sent to shareholders of record within the following seven business days with instructions on how to
respond if they elect to take advantage of the conversion and grant the option to purchase their shares at $.50 per share.
Mr. Schectman and his investor group will have 120 days from the date of agreement to exercise his option to purchase up to 90% of OrderPro Logistics' shares outstanding at
$.50 per share. Upon official notification to exercise this conversion, the company will provide the shareholders of record who have elected to grant the option, detailed instructions
as to the date of execution and how to tender their shares. Owners of 51% of the shares outstanding have already agreed to grant the option to purchase their shares.
In addition, we would like to assure shareholders that the company has not limited its options to attract additional investors or investment capital. Therefore, should the company
receive a bonafied offer for other funding, during the duration of this agreement, Mr. Schectman's investor group will have seven days to execute their option.
We are very optimistic about the progress we have made to date. We have been working very hard to execute our game plan and we are now seeing it come together. This offer is
presented by a solid group of investors that believe in the company and the funding we will obtain through their continued participation will enable us to accomplish our short and
long term objectives by growing its 3PL services globally and securing acquisitions.
Sincerely,
Richard L. Windorski
Richard L. Windorski
President and CEO
XYNY - looking ok on this down day. imo
Shac, you should become a MM and then you can fill our orders. lol
OPLO - news out.
OPLO - news out. $.50 offer is moving forward.
USPT - news. 25 x 1 split
OPLO - watching the bid firm up. Expecting news today per there 2/5 pr on .50 offer.
MYRG .195 x .205
MYRG - in at .16
OPLO - bought more today. expect news mid week.
OPLO - bought more today. Looking for news mid week.
XYNY looking good. imo. eom.
Shac, must be a nice collection. lol eom.
Shac, good - bring it on!!
OPLO buyout news out
got some ZKID @ .052
Art, IBCL
do you know what the float is? Outstanding shares seem to be around 79mill.
I was told that Worldymate passed away peacefully in his sleep in Nov. What a shame.
MYRG - looking good. Only 1.5 mill in the float.
WorldyMate - U still around? You have a PM.